BK
BIO-key International, Inc.
BKYI · NASDAQ
$2.67 -0.56% (-$0.02)
1M -15.61%
Market Cap $2.88M
P/E Ratio -
Div. Yield -
ROE 53.82%
Bulios Fair Price
$3.85
44.5% upside
Current Price
$2.67
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BKYI is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.42x
P/B 0.66x
P/E N/A
Growth
18 /100
Declining Rev. growth 4.60%
Book val. growth 13.09%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 81.75%
Net margin 50.00%
Op. margin 46.42%
Quality
15 /100
Poor ROIC 70.50%
ROE 53.82%
ROA 45.81%
Debt
55 /100
Moderate Debt/Equity 0.03x
Current ratio 1.26x
Int. coverage -16.72x
Stability
60 /100
Moderate Beta 0.40x
Rev. volatility 12.61%
EPS volatility 21.05%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BKYI
Online
Sector
Technology
Industry
Information Technology Services
CEO
Michael W. DePasquale
Employees
42
Headquarters
Holmdel
Upcoming events
13 NOV
Earnings
Upcoming earnings report